1888 related articles for article (PubMed ID: 10376168)
21. Sumatriptan and naproxen sodium for the acute treatment of migraine.
Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study.
Carpay J; Schoenen J; Ahmad F; Kinrade F; Boswell D
Clin Ther; 2004 Feb; 26(2):214-23. PubMed ID: 15038944
[TBL] [Abstract][Full Text] [Related]
23. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
[TBL] [Abstract][Full Text] [Related]
24. Oral sumatriptan for acute migraine.
McCrory DC; Gray RN
Cochrane Database Syst Rev; 2003; (3):CD002915. PubMed ID: 12917936
[TBL] [Abstract][Full Text] [Related]
25. Diclofenac with or without an antiemetic for acute migraine headaches in adults.
Derry S; Rabbie R; Moore RA
Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD008783. PubMed ID: 23633360
[TBL] [Abstract][Full Text] [Related]
26. Sumatriptan (oral route of administration) for acute migraine attacks in adults.
Derry CJ; Derry S; Moore RA
Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD008615. PubMed ID: 22336849
[TBL] [Abstract][Full Text] [Related]
27. Alniditan in the acute treatment of migraine attacks: a subcutaneous dose-finding study. Subcutaneous Alniditan Study Group.
Goldstein J; Dahlöf CG; Diener HC; Olesen J; Schellens R; Senard JM; Simard D; Steiner TJ
Cephalalgia; 1996 Nov; 16(7):497-502. PubMed ID: 8933995
[TBL] [Abstract][Full Text] [Related]
28. A Randomized Trial of Ketorolac vs. Sumatripan vs. Placebo Nasal Spray (KSPN) for Acute Migraine.
Rao AS; Gelaye B; Kurth T; Dash PD; Nitchie H; Peterlin BL
Headache; 2016 Feb; 56(2):331-40. PubMed ID: 26840902
[TBL] [Abstract][Full Text] [Related]
29. Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine.
Nett R; Landy S; Shackelford S; Richardson MS; Ames M; Lener M
Obstet Gynecol; 2003 Oct; 102(4):835-42. PubMed ID: 14551015
[TBL] [Abstract][Full Text] [Related]
30. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
31. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan.
Pfaffenrath V; Cunin G; Sjonell G; Prendergast S
Headache; 1998 Mar; 38(3):184-90. PubMed ID: 9563208
[TBL] [Abstract][Full Text] [Related]
33. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
[TBL] [Abstract][Full Text] [Related]
34. Sumatriptan plus naproxen for acute migraine attacks in adults.
Law S; Derry S; Moore RA
Cochrane Database Syst Rev; 2013 Oct; (10):CD008541. PubMed ID: 24142431
[TBL] [Abstract][Full Text] [Related]
35. Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine-Associated Nausea and Prior Triptan Use on Efficacy.
Lipton RB; Schmidt P; Diener HC
Headache; 2017 May; 57(5):756-765. PubMed ID: 28386945
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group.
Diener HC
Cephalalgia; 1999 Jul; 19(6):581-8; discussion 542. PubMed ID: 10448545
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
[TBL] [Abstract][Full Text] [Related]
38. Sumatriptan is effective in the treatment of menstrual migraine: a review of prospective studies and retrospective analyses.
Salonen R; Saiers J
Cephalalgia; 1999 Jan; 19(1):16-9. PubMed ID: 10099854
[TBL] [Abstract][Full Text] [Related]
39. Acute treatment of migraine attacks.
Ferrari MD; Haan J
Curr Opin Neurol; 1995 Jun; 8(3):237-42. PubMed ID: 7551126
[TBL] [Abstract][Full Text] [Related]
40. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
